Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were diagnosed with Systemic Lupus Erythematosus (SLE, a chronic autoimmune disease) before the age of 18, based on recognised international diagnostic guidelines
- People who showed signs of kidney involvement (through symptoms, blood/urine tests, or kidney biopsy results) before the age of 18
- People who are able to sign a consent form agreeing to participate
Who may not be able to join:
- People whose kidney disease began after the age of 18
- People whose lupus was caused by a medication, or who have lupus alongside another autoimmune condition such as systemic sclerosis, rheumatoid arthritis, Sjögren's syndrome, or a related connective tissue disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carmela Errichiello, Meyer Children's Hospital IRCCS, Florence, Italy
Phone: 055/5662563
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference between monogenic and non-monogenic forms of cSLE; Evaluation of expression of MXA protein in renal biopsy; Evaluation of the proportions of the various WHO histological classes of renal biopsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.